Pyxis Oncology (PYXS) Operating Leases: 2024-2025
Historic Operating Leases for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $17.4 million.
- Pyxis Oncology's Operating Leases fell 8.57% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year decrease of 8.57%. This contributed to the annual value of $18.6 million for FY2024, which is N/A change from last year.
- Per Pyxis Oncology's latest filing, its Operating Leases stood at $17.4 million for Q3 2025, which was down 2.42% from $17.8 million recorded in Q2 2025.
- Pyxis Oncology's Operating Leases' 5-year high stood at $19.8 million during Q1 2024, with a 5-year trough of $17.4 million in Q3 2025.
- For the 2-year period, Pyxis Oncology's Operating Leases averaged around $18.6 million, with its median value being $18.6 million (2024).
- Data for Pyxis Oncology's Operating Leases shows a maximum YoY declined of 8.57% (in 2025) over the last 5 years.
- Pyxis Oncology's Operating Leases (Quarterly) stood at $18.6 million in 2024, then decreased by 8.57% to $17.4 million in 2025.
- Its Operating Leases stands at $17.4 million for Q3 2025, versus $17.8 million for Q2 2025 and $18.3 million for Q1 2025.